| Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic … K Kanasaki, S Shi, M Kanasaki, J He, T Nagai, Y Nakamura, Y Ishigaki, ... Diabetes 63 (6), 2120-2131, 2014 | 364 | 2014 |
| Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition S Shi, SP Srivastava, M Kanasaki, J He, M Kitada, T Nagai, K Nitta, ... Kidney international 88 (3), 479-489, 2015 | 170 | 2015 |
| Renal protective effects of empagliflozin via inhibition of EMT and aberrant glycolysis in proximal tubules J Li, H Liu, S Takagi, K Nitta, M Kitada, SP Srivastava, Y Takagaki, ... JCI Insight, 2020 | 164 | 2020 |
| miR-29a levels are elevated in the db/db mice liver and its overexpression leads to attenuation of insulin action on PEPCK gene expression in HepG2 cells AK Pandey, G Verma, S Vig, S Srivastava, AK Srivastava, M Datta Molecular and cellular endocrinology 332 (1-2), 125-133, 2011 | 141 | 2011 |
| MicroRNAs in kidney fibrosis and diabetic nephropathy: roles on EMT and EndMT SP Srivastava, D Koya, K Kanasaki BioMed research international 2013, 2013 | 136 | 2013 |
| SIRT3 deficiency leads to induction of abnormal glycolysis in diabetic kidney with fibrosis SP Srivastava, J Li, M Kitada, H Fujita, Y Yamada, JE Goodwin, ... Cell death & disease 9 (10), 1-14, 2018 | 128 | 2018 |
| Design and synthesis of 2, 4-disubstituted polyhydroquinolines as prospective antihyperglycemic and lipid modulating agents A Kumar, S Sharma, VD Tripathi, RA Maurya, SP Srivastava, G Bhatia, ... Bioorganic & medicinal chemistry 18 (11), 4138-4148, 2010 | 112 | 2010 |
| Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy SP Srivastava, H Zhou, O Setia, L Liu, K Kanasaki, D Koya, A Dardik, ... Nature Communications 12, 2368, 2021 | 94 | 2021 |
| microRNA Crosstalk Influences Epithelial-to-Mesenchymal, Endothelial-to-Mesenchymal, and Macrophage-to-Mesenchymal Transitions in the Kidney SP Srivastava, AF Hedayat, K Kanasaki, JE Goodwin Frontiers in pharmacology 10, 2019 | 93 | 2019 |
| N-acetyl-seryl-aspartyl-lysyl-proline inhibits diabetes-associated kidney fibrosis and endothelial-mesenchymal transition T Nagai, M Kanasaki, SP Srivastava, Y Nakamura, Y Ishigaki, M Kitada, ... BioMed research international 2014, 2014 | 91 | 2014 |
| Thiazolidin-4-one and thiazinan-4-one derivatives analogous to rosiglitazone as potential antihyperglycemic and antidyslipidemic agents S Raza, SP Srivastava, DS Srivastava, AK Srivastava, W Haq, SB Katti European journal of medicinal chemistry 63, 611-620, 2013 | 87 | 2013 |
| Antidiabetic activity of heart wood of Pterocarpus marsupium Roxb. and analysis of phytoconstituents† A Mishra, R Srivastava, SP Srivastava, S Gautam, AK Tamrakar, ... NISCAIR-CSIR, India, 2013 | 86 | 2013 |
| Inhibition of angiotensin-converting enzyme ameliorates renal fibrosis by mitigating DPP-4 level and restoring antifibrotic MicroRNAs SP Srivastava, JE Goodwin, K Kanasaki, D Koya Genes 11 (2), 211, 2020 | 68 | 2020 |
| Effect of antifibrotic microRNAs crosstalk on the action of N-acetyl-seryl-aspartyl-lysyl-proline in diabetes-related kidney fibrosis SP Srivastava, S Shi, M Kanasaki, T Nagai, M Kitada, J He, Y Nakamura, ... Scientific reports 6 (1), 1-12, 2016 | 68 | 2016 |
| Lipid mediators in diabetic nephropathy SP Srivastava, S Shi, D Koya, K Kanasaki Fibrogenesis & tissue repair 7 (1), 1-10, 2014 | 68 | 2014 |
| Flavone-based novel antidiabetic and antidyslipidemic agents AK Verma, H Singh, M Satyanarayana, SP Srivastava, P Tiwari, AB Singh, ... Journal of medicinal chemistry 55 (10), 4551-4567, 2012 | 63 | 2012 |
| FGFR1 is critical for the anti-endothelial mesenchymal transition effect of N-acetyl-seryl-aspartyl-lysyl-proline via induction of the MAP4K4 pathway J Li, S Shi, SP Srivastava, M Kitada, T Nagai, K Nitta, M Kohno, ... Cell death & disease 8 (8), e2965-e2965, 2017 | 61 | 2017 |
| Cancer biology and prevention in diabetes SP Srivastava, JE Goodwin Cells 9 (6), 1380, 2020 | 58 | 2020 |
| Antidiabetic effect of Eclipta alba associated with the inhibition of alpha-glucosidase and aldose reductase N Jaiswal, V Bhatia, SP Srivastava, AK Srivastava, AK Tamrakar Natural Product Research 26 (24), 2363-2367, 2012 | 58 | 2012 |
| Antidiabetic and antidyslipidemic activities of Cuminum cyminum L. in validated animal models R Srivsatava, SP Srivastava, N Jaiswal, A Mishra, R Maurya, ... Medicinal Chemistry Research 20 (9), 1656-1666, 2011 | 57 | 2011 |
